173 related articles for article (PubMed ID: 38410799)
41. BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer.
Liu B; Liu X; Han L; Chen X; Wu X; Wu J; Yan D; Wang Y; Liu S; Shan L; Zhang Y; Shang Y
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35105803
[TBL] [Abstract][Full Text] [Related]
42. HPV E7 affects the function of cervical cancer cells via the TAL1/lnc‑EBIC/KLHDC7B axis.
Wang J; Xiang F; Liu X; Ma X; Cai X; Yang Y; Shen X; Yuan C; Xiang Y; Xiao H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760214
[TBL] [Abstract][Full Text] [Related]
43. Expression profiling of lncRNAs and mRNAs in placental site trophoblastic tumor (PSTT) by microarray.
Gan J; Chen Z; Feng X; Wei Z; Zhang S; Du Y; Xu C; Zhao H
Int J Med Sci; 2022; 19(1):1-12. PubMed ID: 34975294
[TBL] [Abstract][Full Text] [Related]
44. Alteration of long non-coding RNAs and mRNAs expression profiles by compound heterozygous ASXL3 mutations in the mouse brain.
Zhang S; Fu F; Zhen L; Li R; Liao C
Bioengineered; 2021 Dec; 12(1):6935-6951. PubMed ID: 34559584
[TBL] [Abstract][Full Text] [Related]
45. Analysis of LncRNA-mRNA Co-Expression Profiles in Patients With Polycystic Ovary Syndrome: A Pilot Study.
Sun X; Liu Y; Gao X; Du M; Gao M; Zhong X; Wei X
Front Immunol; 2021; 12():669819. PubMed ID: 33936113
[TBL] [Abstract][Full Text] [Related]
46. Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression.
Li GQ; Guo WZ; Zhang Y; Seng JJ; Zhang HP; Ma XX; Zhang G; Li J; Yan B; Tang HW; Li SS; Wang LD; Zhang SJ
Oncotarget; 2016 Jan; 7(3):2462-74. PubMed ID: 26575167
[TBL] [Abstract][Full Text] [Related]
47. Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.
Jung M; Philpott M; Müller S; Schulze J; Badock V; Eberspächer U; Moosmayer D; Bader B; Schmees N; Fernández-Montalván A; Haendler B
J Biol Chem; 2014 Mar; 289(13):9304-19. PubMed ID: 24497639
[TBL] [Abstract][Full Text] [Related]
48. Long non-coding RNA MANCR is a target of BET bromodomain protein BRD4 and plays a critical role in cellular migration and invasion abilities of prostate cancer.
Nagasawa M; Tomimatsu K; Terada K; Kondo K; Miyazaki K; Miyazaki M; Motooka D; Okuzaki D; Yoshida T; Kageyama S; Kawamoto H; Kawauchi A; Agata Y
Biochem Biophys Res Commun; 2020 May; 526(1):128-134. PubMed ID: 32199616
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of the BET family reduces its new target gene IDO1 expression and the production of L-kynurenine.
Tian CQ; Chen L; Chen HD; Huan XJ; Hu JP; Shen JK; Xiong B; Wang YQ; Miao ZH
Cell Death Dis; 2019 Jul; 10(8):557. PubMed ID: 31324754
[TBL] [Abstract][Full Text] [Related]
50. Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein.
Bartholomeeusen K; Xiang Y; Fujinaga K; Peterlin BM
J Biol Chem; 2012 Oct; 287(43):36609-16. PubMed ID: 22952229
[TBL] [Abstract][Full Text] [Related]
51. Differences in gene expression profile between vocal cord Leukoplakia and normal larynx mucosa by gene chip.
Peng J; Li H; Chen J; Wu X; Jiang T; Chen X
J Otolaryngol Head Neck Surg; 2018 Feb; 47(1):13. PubMed ID: 29433566
[TBL] [Abstract][Full Text] [Related]
52. Genome-wide analysis of differentially expressed profiles of mRNAs, lncRNAs and circRNAs in chickens during Eimeria necatrix infection.
Fan XC; Liu TL; Wang Y; Wu XM; Wang YX; Lai P; Song JK; Zhao GH
Parasit Vectors; 2020 Apr; 13(1):167. PubMed ID: 32245514
[TBL] [Abstract][Full Text] [Related]
53. Genome-wide analysis of differentially expressed lncRNAs and mRNAs in primary gonadotrophin adenomas by RNA-seq.
Li J; Li C; Wang J; Song G; Zhao Z; Wang H; Wang W; Li H; Li Z; Miao Y; Li G; Zhang Y
Oncotarget; 2017 Jan; 8(3):4585-4606. PubMed ID: 27992366
[TBL] [Abstract][Full Text] [Related]
54. SELER: a database of super-enhancer-associated lncRNA- directed transcriptional regulation in human cancers.
Guo ZW; Xie C; Li K; Zhai XM; Cai GX; Yang XX; Wu YS
Database (Oxford); 2019 Jan; 2019():. PubMed ID: 30806704
[TBL] [Abstract][Full Text] [Related]
55. Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells.
Wiese M; Hamdan FH; Kubiak K; Diederichs C; Gielen GH; Nussbaumer G; Carcaboso AM; Hulleman E; Johnsen SA; Kramm CM
Cell Death Dis; 2020 Aug; 11(8):673. PubMed ID: 32826850
[TBL] [Abstract][Full Text] [Related]
56. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma.
Song S; Li Y; Xu Y; Ma L; Pool Pizzi M; Jin J; Scott AW; Huo L; Wang Y; Lee JH; Bhutani MS; Weston B; Shanbhag ND; Johnson RL; Ajani JA
Mol Oncol; 2020 Jun; 14(6):1410-1426. PubMed ID: 32175692
[TBL] [Abstract][Full Text] [Related]
57. BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.
Ott CJ; Kopp N; Bird L; Paranal RM; Qi J; Bowman T; Rodig SJ; Kung AL; Bradner JE; Weinstock DM
Blood; 2012 Oct; 120(14):2843-52. PubMed ID: 22904298
[TBL] [Abstract][Full Text] [Related]
58. JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis.
Zhang Y; Duan S; Jang A; Mao L; Liu X; Huang G
Exp Eye Res; 2021 Jan; 202():108304. PubMed ID: 33080301
[TBL] [Abstract][Full Text] [Related]
59. Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.
Zhang W; Prakash C; Sum C; Gong Y; Li Y; Kwok JJ; Thiessen N; Pettersson S; Jones SJ; Knapp S; Yang H; Chin KC
J Biol Chem; 2012 Dec; 287(51):43137-55. PubMed ID: 23086925
[TBL] [Abstract][Full Text] [Related]
60. The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.
Li Z; Guo J; Wu Y; Zhou Q
Nucleic Acids Res; 2013 Jan; 41(1):277-87. PubMed ID: 23087374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
